Description
MOXISIGN-D EYE/EAR DROPS is a dual-action ophthalmic and otic solution formulated with Moxifloxacin, a potent fourth-generation fluoroquinolone antibiotic, and Dexamethasone, a strong corticosteroid. This combination therapy is ideal for managing bacterial infections that are associated with inflammation, redness, swelling, and discomfort in the eyes or ears.
Bacterial conjunctivitis with inflammation
Post-operative ocular inflammation and infection
**Keratitis and blepharitis with bacterial involvement
Otitis externa with inflammatory symptoms
Ear infections with bacterial discharge and pain
Post-ear surgery prophylaxis against infection/inflammation
Moxifloxacin works by inhibiting DNA gyrase and topoisomerase IV, enzymes that bacteria need to replicate and repair their DNA. This results in effective killing of a broad range of Gram-positive and Gram-negative bacteria.
Dexamethasone reduces the body’s inflammatory response by blocking the production of prostaglandins and other inflammatory mediators. It decreases swelling, redness, and itching quickly.
Combines antibacterial and anti-inflammatory action for comprehensive treatment
Rapid symptom relief: reduces infection, swelling, and pain
Suitable for dual use in eyes and ears
Promotes faster healing post-surgery or trauma
Sterile, stable, and safe for regular use under medical supervision
Easy-to-use dropper for accurate dosing
Eyes: 1–2 drops in the affected eye(s) 3–4 times a day or as directed
Ears: 3–4 drops in the affected ear(s) twice to thrice daily
Wash hands before use, avoid touching dropper tip to prevent contamination
Use only for the prescribed duration to prevent resistance or side effects
Prolonged use without medical supervision may increase the risk of steroid-induced side effects like increased intraocular pressure. Not recommended for viral or fungal infections.
MOXISIGN-D EYE/EAR DROPS is manufactured by Bluepill Express, a well-established Indian pharmaceutical company involved in third-party manufacturing and global supply of medicines across therapeutic categories. With WHO-GMP, ISO, and export licenses, Bluepill Express delivers pharmaceutical excellence across:
Asia
Middle East
Africa
CIS Countries
South America
Europe (under regulatory approval and private label agreements)
Strict adherence to GMP protocols
Sterile, contamination-free production for ophthalmic/otic formulations
Regulatory documentation including COA, MOA, Stability Data, and Shipping Docs
Customization in branding, packaging, and export logistics
This makes MOXISIGN-D EYE/EAR DROPS a trusted choice for healthcare providers, pharmacists, government tenders, and institutional buyers worldwide.
